Waldo I. Ortuzar
Impact in
- Oncology top 10%
- Metal complexes synthesis and properties
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Metal complexes synthesis and properties 2
- Lung Cancer Research Studies 1
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Tito Fojo (2 shared papers)Olivier Rixe (1 shared paper)Eddie Reed (1 shared paper)Manuel Álvarez (1 shared paper)R. R. Parker (1 shared paper)Ken Paull (1 shared paper)Ralph Zinner (2 shared papers)Hideyuki Tanimura (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Clinical Lung Cancer (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Nature Communications (1 paper)BMC Cancer (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Waldo I. Ortuzar
10 papers receiving 781 citations
Peers
Comparison fields: 5 of 73
- Oncology 489
- Pulmonary and Respiratory Medicine 147
- Cancer Research 58
- Organic Chemistry 115
- Pathology and Forensic Medicine 63
Countries citing papers authored by Waldo I. Ortuzar
This map shows the geographic impact of Waldo I. Ortuzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldo I. Ortuzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldo I. Ortuzar more than expected).
Fields of papers citing papers by Waldo I. Ortuzar
This network shows the impact of papers produced by Waldo I. Ortuzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldo I. Ortuzar. The network helps show where Waldo I. Ortuzar may publish in the future.
Co-authors
The 25 scholars most cited alongside Waldo I. Ortuzar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 532 | |
| 2 | 2014 | 135 | |
| 3 | 2004 | 48 | |
| 4 | 2008 | 34 | |
| 5 | 2011 | 25 | |
| 6 | 2024 | 18 | |
| 7 | 2010 | 14 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 3 | |
| 10 | 2018 | 2 |
About Waldo I. Ortuzar
Waldo I. Ortuzar is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Computational Theory and Mathematics, having authored 10 papers that have together received 817 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Metal complexes synthesis and properties (2 papers), Cancer Genomics and Diagnostics (1 paper), COVID-19 Clinical Research Studies (1 paper), Immunotherapy and Immune Responses (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (489 citations), Pulmonary and Respiratory Medicine (147 citations), Cancer Research (58 citations), Organic Chemistry (115 citations) and Pathology and Forensic Medicine (63 citations). Waldo I. Ortuzar has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Tito Fojo, Olivier Rixe, Eddie Reed, Manuel Álvarez, R. R. Parker, Ken Paull, Ralph Zinner, Hideyuki Tanimura, Timothy G. Myers and John N. Weinstein. Their work appears in journals such as Annals of Oncology, Clinical Lung Cancer, Critical Reviews in Oncology/Hematology, Nature Communications and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.